AHA officials penned a Medical Economics op-ed on “the truth behind growth of the 340B prescription drug program.”

AHA Op-Ed Takes Aim at ‘Big Pharma’s’ 340B Program Growth Rhetoric

September 24, 2024 Shannon Young, Associate Editor/Senior Writer Views

A major hospital group recently hit back against the drug industry’s claims that hospital behavior has helped drive “out of [...]

Please Login or Become a Paid Subscriber to View this Content

Please be sure you’ve completed your one-minute subscription completion form.
I have read and accepted the terms of use and privacy policy.
Log In!